Gastroesophageal reflux disease with fibers formed of β-1-4-glucan
US12220425B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 16, 2021 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Nov 16, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a method of preventing or treating gastroesophageal reflux disease, including administering to an subject in need thereof a composition including a plurality of fibers formed of β-1-4-glucan, wherein the fibers have a diameter between 15 nm and 35 nm and a mean length of between 1.5 μm and 3.5 μm.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.